Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Inks Deal to Supply California with Spectrometry Systems

NEW YORK, Nov. 8 (GenomeWeb News) - PerkinElmer said today that it has signed agreements to provide California with tandem mass spectrometry systems to support the state's expanded newborn screening program.

 

According to PerkinElmer, it will provide California's contracted newborn screening laboratories with tandem mass spectrometry systems, reagent kits, and software. Additionally, a system will be installed at California's Genetic Disease Laboratory, which will analyze results from the screening labs and perform quality control oversight.

 

PerkinElmer also said it will provide the state's contracted newborn screening laboratories with 17-OHP assay kits for the screening of congenital adrenal hyperplasia. The company expects this system will be available for sale in late 2004 or early 2005.

 

Additional terms of the arrangements were not disclosed.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.